Polymer Supported Synthesis, E.g., Solid Phase Synthesis, Merrifield Synthesis, Etc. Patents (Class 530/334)
-
Patent number: 6919211Abstract: The present invention provides methods and apparatus for sequencing, fingerprinting and mapping biological macromolecules, typically biological polymers. The methods make use of a plurality of sequence specific recognition reagents which can also be used for classification of biological samples, and to characterize their sources.Type: GrantFiled: September 1, 2000Date of Patent: July 19, 2005Assignee: Affymetrix, Inc.Inventors: Stephen P. A. Fodor, J. Leighton Read, Lubert Stryer, Michael C. Pirrung
-
Patent number: 6914121Abstract: PEG-LHRH analog conjugates, where a PEG moiety is covalently bound to a serine residue of a LHRH analog either directly or via a bifunctional linker molecule, such as an amino acid, and methods for producing these conjugates are provided in the present invention. Also provided are a pharmaceutical composition and a method for treating pathologies in which LHRH analog administration is beneficial.Type: GrantFiled: June 28, 2002Date of Patent: July 5, 2005Assignee: Applied Research Systems Ars Holding N.V.Inventors: Nabil El-Tayar, Xuan Zhao, Michael D. Bentley
-
Patent number: 6911425Abstract: Peptide sequences comprising 10 to 50 amino acids are disclosed. The sequences are characterized by containing at least one of an integrin binding motif such as an RGD sequence, a glycosaminoglycan binding motif, and a calcium binding motif, and the remainder of amino acids contiguous with the RGD sequence in matrix extracellular phosphoglycoprotein. The sequences may be formulated for injection or dispersed in toothpaste or a mouthwash or gum patch and administered to enhance bone/tooth growth and/or reduce excessive urinary phosphate loss from the body.Type: GrantFiled: March 19, 2001Date of Patent: June 28, 2005Assignee: Acologix, Inc.Inventors: Yoshinari Kumagai, Toshiyuki Yoneda, Russell Wayne Blacher
-
Patent number: 6906035Abstract: A novel class of cationic peptides having antimicrobial activity is provided. Examples of such peptides include NH2-KWKSFIKKLTTAVKKVLTTGLPALIS-COOH (SEQ ID NO:1) and NH2-KWKSFIKKLTSAAKKVVTTAKPLISS-COOH (SEQ ID NO:2). Also provided are methods for inhibiting the growth of bacteria utilizing the peptides of the invention. The peptides are particularly useful for inhibiting endotoxemia in a subject.Type: GrantFiled: October 15, 2002Date of Patent: June 14, 2005Assignee: The University of British ColumbiaInventors: Robert E. W. Hancock, Nedra Karunaratne
-
Patent number: 6893614Abstract: The present invention relates to a reaction vessel for organic synthesis and a block device for the reaction vessel and synthetic method of compound using thereof. More particularly, the present invention provides a solid phase synthetic reaction vessel and a block device for the reaction vessels which are capable of simultaneously synthesizing chemical libraries by combinatorial chemistry method automatically or semiautomatically.Type: GrantFiled: February 16, 2001Date of Patent: May 17, 2005Assignee: Peptron IncInventors: Ho-Il Choi, Seung-Gu Chang, Sun-Young Kim, Seong-Kyu Kim, Jeong-Kyu Bang
-
Patent number: 6887665Abstract: Radiation-activated catalysts (RACs), autocatalytic reactions, and protective groups are employed to achieve a highly sensitive, high resolution, radiation directed combinatorial synthesis of pattern arrays of diverse polymers. When irradiated, RACs produce catalysts that can react with enhancers, such as those involved in autocatalytic reactions. The autocatalytic reactions produce at least one product that removes protecting groups from synthesis intermediates. This invention has a wide variety of applications and is particularly useful for the solid phase combinatorial synthesis of polymers.Type: GrantFiled: August 3, 2001Date of Patent: May 3, 2005Assignee: Affymetrix, Inc.Inventors: Mark Trulson, Glenn McGall, Jacqueline Fidanza
-
Patent number: 6875620Abstract: A process of constructing an array of chemical moieties having the following steps: forming multiple discrete physical entities (tiles) from a substantially planar material having one or more species of chemical moiety attached thereto; and picking and placing the entities (tiles) stably on a support at spatially distinct ascertainable locations to form an array of chemical moieties. The formed array includes at least two species of chemical moiety and preferably from about 50 to about 1000 species. The claimed invention includes an array formed by this process.Type: GrantFiled: October 31, 1996Date of Patent: April 5, 2005Assignee: Agilent Technologies, Inc.Inventor: Carol T. Schembri
-
Patent number: 6875594Abstract: The present invention provides a method of cleaving a recombinantly expressed protein from an intein and ligating the protein to a peptide containing an N-terminal cysteine having an unoxidized sulfhydryl side chain which comprises contacting the protein with the peptide in a reaction solution comprising a conjugated thiophenol, thereby forming a C-terminal thioester of the recombinant protein which spontaneously rearranges intramolecularly to form an amide bond linking the protein to the peptide.Type: GrantFiled: July 12, 2001Date of Patent: April 5, 2005Assignee: The Rockefeller UniversityInventors: Tom W. Muir, Philip A. Cole, Dolan Sondhi, Konstantine Severinov
-
Patent number: 6864357Abstract: The present invention relates to a process for the preparation of peptides using an excess of an activated carboxylic component to acylate an amino component, wherein after the acylation an amine comprising a free anion or a latent anion is used as a scavenger of residual activated carboxylic functions. This process is useful for the preparation of oligo- and polypeptides and, more generally, in the preparation of compounds containing one or more amide bonds.Type: GrantFiled: July 19, 2002Date of Patent: March 8, 2005Assignee: Akzo Nobel N.V.Inventors: Ivo Franci Eggen, Paulus Bernardus Wilhelmus Ten Kortenaar
-
Patent number: 6849596Abstract: This invention describes novel charged molecules which specifically bind to the Hepreceptor, a regulatory site which I have discovered in human ezrin. My invention is that when peptides or other charged molecules bind to the Hepreceptor, medically useful immune responses are induced. These charged molecules can be administered orally and by other routes for the treatment of various infectious diseases and cancer. I have determined that the Hepreceptor (human ezrin 308-373) comprises of two adjacent alpha helical domains which are folded together at a hinge region (M339-M340) and stabilised by complimentary side chain charges of the primary amino acid sequence in the soluble cytoplasmic conformation of ezrin. I have determined that in the unfolded membrane associated conformation of ezrin, the Hepreceptor is pushed through the cell membrane and is exposed on the outer surface of the cell. Hepreceptor-Domain A (amino acid numbers 308-339 of human ezrin), comprises of the following 32 amino acid sequence.Type: GrantFiled: September 15, 2000Date of Patent: February 1, 2005Inventor: Rupert Donald Holms
-
Patent number: 6831066Abstract: Compounds that modulate natural &bgr; amyloid peptide aggregation are provided. The modulators of the invention comprise a peptide, preferably based on a &bgr; amyloid peptide, that is comprised entirely of D-amino acids. Preferably, the peptide comprises 3-5 D-amino acid residues and includes at least two D-amino acid residues independently selected from the group consisting of D-leucine, D-phenylalanine and D-valine. In a particularly preferred embodiment, the peptide is a retro-inverso isomer of a &bgr; amyloid peptide, preferably a retro-inverso isomer of A&bgr;17-21. In certain embodiments, the peptide is modified at the amino-terminus, the carboxy-terminus, or both. Preferred amino-terminal modifying groups alkyl groups. Preferred carboxy-terminal modifying groups include an amide group, an acetate group, an alkyl amide group, an aryl amide group or a hydroxy group.Type: GrantFiled: March 24, 2003Date of Patent: December 14, 2004Assignee: Praecis Pharmaceuticals IncorporatedInventors: Mark A. Findeis, Kathryn Phillips
-
Patent number: 6797522Abstract: The invention is directed to synthetic receptor(s) which comprises a polyfunctional organic template covalently linked to two or more oligomers which may independently be the same or different and may independently be straight chain, cyclic or branched. The template may be linked to an identifier which uniquely defines the synthetic receptor. The identifier is a stable chemical molecule or a plurality of stable chemical molecules distinguishable and detectable to picomolar levels or may be an oligonucleotide. In a preferred embodiment, the template is covalently linked to a solid support which is linked to an identifier. In addition, the invention includes methods of preparing synthetic receptors and synthetic receptor libraries. The synthetic library may be linked with identifiers such that the library comprises a plurality of different synthetic receptor members.Type: GrantFiled: March 12, 1998Date of Patent: September 28, 2004Assignee: The Trustees of Columbia University in the City of New YorkInventors: W. Clark Still, Ge Li, Helma Wennemers
-
Patent number: 6787635Abstract: Functionalized supports and methods for solid phase synthesis. Preferably, the functionalized support is azlactone-functionalized.Type: GrantFiled: April 5, 2001Date of Patent: September 7, 2004Assignee: 3M Innovative Properties CompanyInventors: Jerald K. Rasmussen, Larry R. Krepski
-
Publication number: 20040158037Abstract: The present invention relates to a process for making a biologically active substance or therapeutic agent free of a chlorotrityl chloride linker-resin. The process includes reacting an activated amino acid or activated amino acid derivative with a substituted or unsubstituted trityl alcohol resin to obtain a resin-CT-AA product; and, reacting the resin-CT-AA product with other building blocks of the biologically active substance or therapeutic agent to obtain said biologically active substance or therapeutic. A product created by this process is also provided herein. The invention is particularly useful to create T-20 and T-1249 therapeutics.Type: ApplicationFiled: January 22, 2004Publication date: August 12, 2004Inventors: James Charles Bohling, John Joseph Maikner, Marlin Kenneth Kinzey, Witold Andrew Ziarno
-
Patent number: 6774102Abstract: This invention describes blood treating material having the capacity to selectively remove endotoxin and cytokine inducing substances from blood or plasma by extracorporeal adsorption for therapeutic septic shock treatment. The endotoxin adsorption ligands of the invention are oligopeptides synthesized from amino acids having a pk>7.2 such as arginine, lysine or histidine, using a polycondensation step such that the resultant oligopeptides exhibit a high degree of polydispersity. Also provided are methods and devices using an adsorbent having a polydisperse oligopeptide of the invention immobilized on a solid state support medium for removing endotoxin from the blood of human or animal subject.Type: GrantFiled: September 15, 2000Date of Patent: August 10, 2004Assignee: Gambro Dialysatoren GmbH & Co. KGInventors: Carl-Martin Bell, Markus Storr, Werner Beck
-
Patent number: 6774103Abstract: This invention relates to determining the three-dimensional structure of the cytosolic domain of phospholamban (PLB) and its active site from NMR data of sufficiently high resolution for the three-dimensional structure determination. The invention also relates to methods for rational drug design enabling the design of phospholamban inhibitors based on using the three-dimensional structure data provided on computer readable media, as analyzed on a computer system having suitable computer algorithms. The invention also relates to phospholamban inhibiting compounds with certain structural, physicochemical and spatial characteristics that allow for the interaction of said compounds with specific residues of the active site of phospholamban.Type: GrantFiled: November 28, 2000Date of Patent: August 10, 2004Assignee: Orion CorporationInventors: Piero Pollesello, Martti Ovaska, Jukka Tenhunen, Jukka Vidgren, Marjo Yliperttula-Ikonen, Carola Tilgmann, Timo Lotta, Juha Kaivola
-
Patent number: 6770436Abstract: Radiation-activated catalysts (RACs), autocatalytic reactions, and protective groups are employed to achieve a highly sensitive, high resolution, radiation directed combinatorial synthesis of pattern arrays of diverse polymers. When irradiated, RACs produce catalysts that can react with enhancers, such as those involved in autocatalytic reactions. The autocatalytic reactions produce at least one product that removes protecting groups from synthesis intermediates. This invention has a wide variety of applications and is particularly useful for the solid phase combinatorial synthesis of polymers.Type: GrantFiled: May 25, 2000Date of Patent: August 3, 2004Assignee: Affymetrix, Inc.Inventors: Jody E. Beecher, Martin J. Goldberg, Glenn H. McGall
-
Publication number: 20040147717Abstract: The present invention relates to a recycling process for the preparation of solid phase bonded 2-chlorotrityl chloride (2-CTC resin) useful for solid phase peptide synthesis, wherein active chloride CTC resin is regenerated by reacting the spent resin with a chlorinating agent in organic solvent.Type: ApplicationFiled: December 18, 2003Publication date: July 29, 2004Inventors: Kleomenis Barlos, Bernhard Knipp
-
Patent number: 6753449Abstract: Cleavable alkene-containing linkers and supports useful for the solid phase synthesis of chemical compounds, and combinatorial libraries of compounds, are disclosed. Also disclosed are methods of making and using the linkers and supports.Type: GrantFiled: October 9, 2001Date of Patent: June 22, 2004Assignee: ArQule, Inc.Inventor: MaoJun Guo
-
Publication number: 20040115759Abstract: The present invention provides a method for acylating one or more amino groups of a peptide where the acylation reaction is to be performed in an aqueous mixture containing less than 10% w/w aprotic polar solvent.Type: ApplicationFiled: September 25, 2003Publication date: June 17, 2004Inventors: Dorte Lunoe Dunweber, Inge Holm Jensen, Louis Brammer Hansen
-
Patent number: 6749756Abstract: A method of separating compounds that includes the steps of: tagging at least a first organic compound with a first tagging moiety to result in a first tagged compound; tagging at least a second organic compound with a second tagging moiety different from the first tagging moiety to result in a second tagged compound; and separating the first tagged compound from a mixture including the second tagged compound using a separation technique based upon differences between the first tagging moiety and the second tagging moiety. The present invention also provides a method for carrying out a chemical reaction including the steps of: tagging a plurality of compounds with different tagging moieties to create tagged compounds, conducting at least one chemical reaction on a mixture of the tagged compounds to produce a mixture of tagged products, and separating the mixture of tagged products by a separation technique based upon differences in the tagging moieties.Type: GrantFiled: February 18, 2000Date of Patent: June 15, 2004Assignee: University of PittsburghInventors: Dennis P. Curran, Oscar de Frutos Garcia, Yoji Oderaotoshi
-
Patent number: 6750312Abstract: A method for preparing a solid support material for carrying out a chemical reaction, said method comprising the following steps: (i) reacting an amino functionalised solid material with a carboxylic acid having at least two similarly protected amino groups to form amide bonds between them, (ii) removing protecting groups in a single step, (iii) optionally repeating steps (i) and (ii) one or more times using the product of the preceding step as the amino functionalised solid material, and (iv) connecting a linkage agent to at least some of the free NH2 groups of the product. The method increases the loading capacity of the solid support material. It is particularly useful in connection with peptide synthesis.Type: GrantFiled: March 26, 2002Date of Patent: June 15, 2004Assignee: Avecia LimitedInventors: Craig Stephen Harris, Donald Alfred Wellings, Francis Joseph Montgomery, Richard John Brown
-
Publication number: 20040087768Abstract: The present invention relates to a process for rapid solution synthesis of a peptide, the process comprising repetitive cycles of steps (a)-(d):Type: ApplicationFiled: October 23, 2003Publication date: May 6, 2004Inventors: Ivo Franci Eggen, Paulus Bernardus Wilhelmus Ten Kortenaar, Cornelis Albert Gruson Haasnoot
-
Publication number: 20040082760Abstract: The present invention relates to a process for rapid solution synthesis of a peptide, the process comprising repetitive cycles of steps (a)-(d):Type: ApplicationFiled: October 22, 2003Publication date: April 29, 2004Inventors: Ivo Franci Eggen, Paulus Bernardus Wilhelmus Ten Kortenaar, Cornelis Albert Gruson Haasnoot
-
Publication number: 20040077830Abstract: Method for preparing a peptide or a peptide derivative comprising at least 2 enantiopure amino acids and at least one glycine molecule, comprising the reaction of a compound of general formula XCH2—C(═O)—HN—A—COOY (II) with a compound of general formula HNR1R2 (III).Type: ApplicationFiled: October 2, 2003Publication date: April 22, 2004Inventors: Roland Callens, Frank Becu, Frans Borremans
-
Publication number: 20040072984Abstract: Described are methods of production of polysuccinimides having molecular weights up to 200,000 daltons and higher. The polysuccinimides of the invention are essentially unbranched and uncrosslinked. They can be modified by crosslinking, ring-opening, and/or other functionalization, if desired, to form gelling materials of superior performance. The high Mw polysuccinimides are also particularly useful as thickening agents, viscosity modifiers, emollients, humectants and in other applications that are known in the art to be serviced most effectively by molecules of higher molecular weight.Type: ApplicationFiled: July 29, 2003Publication date: April 15, 2004Inventor: C. Steven Sikes
-
Patent number: 6713580Abstract: The present invention relates to novel templates useful for generating novel compounds and to compounds produced utilizing the templates. The templates comprise quaternary amino acids that may be linked to solid supports. These templates make possible the production of novel classes of chemical compounds through a plurality of chemical reactions. The templates are advantageous for use in drug discovery regimes.Type: GrantFiled: December 6, 2001Date of Patent: March 30, 2004Assignee: Pharmacore, Inc.Inventors: Michael Johnson, Keqiang Li, Elso DiFranco, Daljit S. Dhanoa
-
Patent number: 6703480Abstract: Novel peptide dimers are provided that bind and activate the erythropoietin receptor (EPO-R) or otherwise act as an EPO agonist. The novel compounds have a first peptide chain R1 and a second peptide chain R2, wherein R1 and R2 may be the same or different, and are linked through a linking moiety. R1 is approximately 10 to 40 amino acid residues in length and comprises the sequence X3X4X5GPX6TX7X8X9 (SEQ ID NO: 1) wherein X3 is C or Hoc, X4 is R, H, L or W, X5 is M, F, I or nor-leucine (J), X6 is any one of the 20 genetically coded L-amino acids or J, X7 is W, 1-naphthylalanine (B) or 2-naphthylalanine (U), X8 is D, E, 1, L or V, and X9 is C or Hoc. Similarly, R2 comprises the sequence X′3X′4X′5GPX′6TX′7X′8X′9 (SEQ ID NO: 2) wherein X′3 is C or Hoc, X′4 is R, H, L or W, X′5 is M, F, I or J, X′6 is any one of the 20 genetically coded L-amino acids or J, X′7 is W, B or U, X8′ is D, E, I, L or V, and X′9 is C or Hoc.Type: GrantFiled: November 24, 1999Date of Patent: March 9, 2004Inventor: Palani Balu
-
Patent number: 6699665Abstract: A multiple level micro-array system for integrating micro-arrays of biomolecules, including biological, chemical and biochemical elements. The multiple level micro-arrays are formed using soft lithography techniques and elastomeric membranes to shield or pattern various portions of a suitable substrate with biomolecules. Additional levels are formed using membranes with various through holes which either isolate, stratify or shield the patterned biomolecules from subsequent patterning or addition of an assay solution.Type: GrantFiled: November 8, 2000Date of Patent: March 2, 2004Assignee: Surface Logix, Inc.Inventors: Enoch Kim, David Duffy
-
Patent number: 6693168Abstract: Methods for preparing chiral non-racemic cyanoamines are provided. The methods are useful, e.g., for preparing chiral amino acids.Type: GrantFiled: September 14, 1999Date of Patent: February 17, 2004Assignee: The Trustees of Boston CollegeInventors: Amir Hoyeyda, Marc L. Snapper, Kevin Kuntz, Clinton A. Krueger, Carolyn Dzierba
-
Patent number: 6683052Abstract: The invention concerns any lipopeptide characterized in that it comprises: a peptide part comprising the peptide sequence consisting of about 30 to about 50 of the last contiguous amino acids of the interferon-&ggr; (IFN-&ggr;) C-terminal end of mammals, whereof, if required, the last 3 to 20 amino acids have been suppressed; and one or several lipophilic parts comprising C4-C20 chain of carbon atoms, saturated or unsaturated, linear or branched, or a steroid group. The invention also concerns any lipopeptide such as defined above containing one or several CD8, and/or CD4, and/or B epitopes. The invention further concerns medicines or vaccines containing any polypeptide such as defined above.Type: GrantFiled: November 20, 2000Date of Patent: January 27, 2004Assignees: Institut National de la Sante et de la Recherche Medicale Inserm, Institut Pasteur de Lille, Centre National de la Recherche ScientifiqueInventors: Kader Thiam, Claude Auriault, Helene Gras-Masse, Estelle Loing, Claudie Verwaerde, Jean Gerard Guillet
-
Patent number: 6680178Abstract: A method is presented for the preparation and use of fluorogenic peptide substrates that allows for the configuration of general substrate libraries to rapidly identify the primary and extended specificity of enzymes, such as proteases. The substrates contain a fluorogenic-leaving group, such as 7-amino-4-carbamoylmethyl-coumarin (ACC). Substrates incorporating the ACC leaving group show comparable kinetic profiles as those with the traditionally used 7-amino-4-methyl-coumarin (AMC) leaving group. The bifunctional nature of ACC allows for the efficient production of single substrates and substrate libraries using solid-phase synthesis techniques. The approximately 3-fold increased quantum yield of ACC over AMC permits reduction in enzyme and substrate concentrations. As a consequence, a greater number of substrates can be tolerated in a single assay, thus enabling an increase in the diversity space of the library.Type: GrantFiled: May 25, 2001Date of Patent: January 20, 2004Assignee: The Regents of the University of CaliforniaInventors: Jennifer L. Harris, Bradley J. Backes, Jonathan A. Ellman, Charles S. Craik
-
Patent number: 6670447Abstract: This invention provides amino acid N-carboxyanhydrides, each of which has an N-acyl substituent on its nitrogen atom, is represented by the following formula (1): readily reacts with nucleophilic reagents such as free amino acids, alcohols, anions or the like, and are intermediates useful for the high-yield production of amino acid derivatives, optically active compounds, peptides, polypeptides and the like useful in many fields lead by the fields of pharmaceuticals and agrochemicals, and also provides a process for the production of the amino acid N-carboxyanhydrides. Further, the present invention also provides a process for the production of diamides, which uses the compounds of the formula (1) and amine derivatives represented by the following formula (7): These diamides can also be suitably used for the production of amino acid derivatives, optically active compounds, peptides, polypeptides and the like.Type: GrantFiled: March 4, 2002Date of Patent: December 30, 2003Assignee: Mitsui Chemicals, Inc.Inventors: Hidetoshi Tsunoda, Michiru Sekiguchi, Hajime Iizuka, Kazuya Sakai
-
Patent number: 6664372Abstract: Peptidomimetic azatides and combinatorial oligoazitide libraries are produced by means of a stepwise synthesis. Combinatorial library construction of this new biomimetic polymer provides a means to fabricate global peptidomimetic libraries.Type: GrantFiled: September 1, 1998Date of Patent: December 16, 2003Assignee: The Scripps Research InstituteInventors: Kim D. Janda, Hyunsoo Han
-
Patent number: 6660466Abstract: Compositions comprising novel di-nitrogen heterocycle compounds containing at least one N-meta-substituted alkaryl group are prepared. The compounds of the present invention are useful as antibacterial and as other pharmaceutical agents and as intermediates for preparation of other pharmaceutical agents. In addition, compounds of the present invention are useful as research reagents.Type: GrantFiled: August 3, 1998Date of Patent: December 9, 2003Assignee: ISIS Pharmaceuticals, Inc.Inventors: Phillip Dan Cook, Pei-Pei Kung, Andrew Mamoru Kawasaki
-
Patent number: 6649348Abstract: Apparatus and methods are disclosed for synthesizing a plurality of compounds on the surface of supports. Biopolymer features are attached to the surfaces of the supports. The synthesis generally comprises a plurality of steps. In the present invention at least two of the steps are performed by placing a support having a functionalized surface into a chamber of a flow cell and subjecting the surface to a step of the synthesis and placing the support into a chamber of another flow cell and subjecting the surface to another step of the synthesis. An apparatus generally comprises a plurality of flow cells and one or more fluid dispensing stations are mounted on the platform and are in fluid communication with one or more of the plurality of flow cells. A station for monomer addition to the surface of the support is mounted on the platform. The apparatus further comprises a mechanism for moving a support to and from the station for monomer addition and a flow cell and from one flow cell to another flow cell.Type: GrantFiled: June 29, 2001Date of Patent: November 18, 2003Assignee: Agilent Technologies Inc.Inventors: Jay K. Bass, John F. McEntee, Tim J. Lazaruk, Maryam Mobed-Miremadi
-
Patent number: 6624144Abstract: The present invention relates to novel matrix metalloproteinase (MMP) inhibitors and down-regulators, to a process for the preparation of these inhibitors, to pharmaceutical compositions comprising these inhibitors/down-regulators, to the use of the novel MMP inhibitors for the manufacture of pharmaceutical and research preparations, to a method for inhibiting and down-regulating MMP-dependent conditions either in vivo or in vitro, to a method for inhibiting formation, synthesis, expression activations, and/or functions as well as actions of matrix metalloproteinases, and to the use of the novel MMP inhibitors and down-regulators in biochemical isolation and purification procedures of matrix metalloproteinases.Type: GrantFiled: November 20, 2000Date of Patent: September 23, 2003Assignee: CTT Cancer Targeting Technologies OyInventors: Erkki Koivunen, Timo Sorsa, Tuula Salo
-
Patent number: 6617307Abstract: A peptide has any one of the sequences SEQ ID NO.1 to SEQ ID NO.8, or has a sequence derived from any one of the sequences SEQ ID NO.1 to SEQ ID NO.8 by substitution, deletion or addition of one or several amino acids therein and having an osteogenetic activity.Type: GrantFiled: November 12, 1999Date of Patent: September 9, 2003Assignees: Kyocera CorporationInventors: Yoshihiko Nishimura, Yoshihisa Suzuki, Masao Tanihara
-
Patent number: 6613876Abstract: Disclosed are &bgr;-peptides containing cylcoalkyl, cycloalkenyl, and heterocylic substituents which encompass the &agr; and &bgr; carbons of the peptide backbone. The &bgr;-peptides adopt stable helical and sheet structures in both the solid state and in solution. Method of generating combinatorial libraries of peptides containing &bgr;-peptide residues and the libraries formed thereby are disclosed.Type: GrantFiled: December 15, 1999Date of Patent: September 2, 2003Assignee: Wisconsin Alumni Research FoundationInventors: Samuel H. Gellman, Daniel H. Appella, Laurie A. Christianson, Daniel A. Klein, Susanne Krauthäuser, Yong Jun Chung, Xifang Wang
-
Patent number: 6613745Abstract: The present invention relates generally to peptide molecules and to derivatives, homologues, analogues and mimetics thereof capable of inducing or facilitating analgesia or partial analgesia alone or in combination with other analgesic molecules. The present invention also contemplates a method of inducing or facilitating analgesia or partial analgesia by the administration of a peptide or a derivative, homologue, analogue or mimetic thereof. The amino acid sequence of the peptide molecules of the present invention are derived from or based on amino acid sequences of snake venom toxins, and, in particular, &agr;-neurotoxins.Type: GrantFiled: July 26, 2000Date of Patent: September 2, 2003Assignee: National University of SingaporeInventors: Ponnampalam Gopalakrishnakone, Xiao Chun Pu, Peter Tsun-Hon Wong, Mathew Choon Eng Gwee, R. Manjunatha Kini
-
Patent number: 6613893Abstract: A method, apparatus, and computer program, for fabricating multiple arrays arranged successively in a first direction on a substrate and each having multiple feature sets arranged successively in the first direction within the array. The method uses a head system having multiple successive sets of dispensers. In the method, the head system is advanced in the first direction over the substrate while dispensing drop sets for each array from dispenser sets so as to form the arrays. In one aspect, drop sets are dispensed in an order the reverse of that from which the dispenser sets pass over a given location on the substrate as the head system advances in the first direction. In this case, each dispenser set deposits a drop set at a distance ahead of a drop set deposited by a preceding dispenser set which is less than the distance to the successive drop dispenser set which deposits the next drop set.Type: GrantFiled: July 31, 2000Date of Patent: September 2, 2003Assignee: Agilent Technologies Inc.Inventor: Peter G. Webb
-
Patent number: 6600016Abstract: Multifunctionalized support resin for the solid phase synthesis of combinatorial libraries is disclosed. The support resin comprises a resin backbone to which is attached a template containing at least two more attachment points which carry mutiple functionalized benzyl-type linkers. Each linker displays differing chemical stability under cleavage conditions so that products can be selectively and sequentially cleaved and separated from the reaction vessel. The linkers are independently different benzyl-type moieties, and each product synthesized on the linkers may have a different chemical structure. The support resin may further comprise an additional linker which is directly attached to the resin backbone. This linker can benzyl-type linkers or other traditional cleavable-linkers. The invention is further directed to a method for the production of mutiple combinatorial libraries in a simultaneous fashion utilizing the above described support resin.Type: GrantFiled: August 24, 1999Date of Patent: July 29, 2003Assignee: Advanced Syntech LLCInventors: Eugene Campian, Boliang Lu, Jinfang Zhang
-
Patent number: 6593455Abstract: Embodiments relate to the discovery that tripeptide amides, which correspond to viral capsid sequences, can be used to inhibit viral infection, including human immunodeficiency virus (HIV) infection. More specifically, medicaments comprising tripeptide amides and methods of using said compounds for the prevention and treatment of viral infection, such as HIV infection, are provided.Type: GrantFiled: August 24, 2001Date of Patent: July 15, 2003Assignee: Tripep ABInventors: David van der Spoel, Csaba Hetényi, Ákos Végvári, Stefan Höglund, Jin Su, Sarah Sandin-Reneby, Laura Goobar-Larsson, Anders Vahlne
-
Patent number: 6590092Abstract: Universal solid supports suitable for use synthesizing of oligonucleotides. The solid supports may be used irrespective of the first RNA or DNA nucleotide to be synthesized, and irrespective of the type of monomer reagent used during the synthesis, that is, irrespective of the type of substitution of the phosphate group in the 3′ position or in the 5′ position depending on whether the synthesis is carried out in the 5′ to 3′ or 3′ to 5′ direction. Following synthesis of the oligonucleotide, deprotection of protecting groups and cleavage of the oligonucleotide from the solid support is accomplished with treatment with standard basic media such as NH4OH, NaOH, methylamine.Type: GrantFiled: May 19, 1999Date of Patent: July 8, 2003Inventor: Nam Q. Ngo
-
Patent number: 6586187Abstract: Compounds of the formula are useful in the treatment of various disorders including, but not limited to, cancer (tumor metathesis, tumorgenesis/tumor growth), angiogenesis (as in cancer, diabetic retinopathy, rheumatoid arthritis), restenosis (following balloon angioplasty or stent implantation), inflammation (as in rheumatoid arthritis, psoriasis), bone diseases (osteopenia induced by bone metastases, immobilization and glucocortocoid treatment, periodontal disease, hyperparathyroidism and rheumatoid arthritis), and as antiviral agents. Novel method of making compounds of formula I are also provided.Type: GrantFiled: April 13, 2000Date of Patent: July 1, 2003Assignee: WyethInventors: Ariamala Gopalsamy, Hui Y. Yang
-
Publication number: 20030113237Abstract: The present invention relates to polymer synthesizers and methods of using polymer synthesizers. For example, the present invention provides highly efficient, reliable, and safe synthesizers that find use, for example, in high throughput and automated nucleic acid synthesis. The present invention also relates to synthesizer arrays for efficient, safe, and automated processes for the production of large quantities of polymers.Type: ApplicationFiled: August 15, 2001Publication date: June 19, 2003Applicant: Third Wave Technologies, Inc.Inventors: Raymond F. Cracauer, Zbigniev Skrzypczynski, Ned D. Reimer
-
Publication number: 20030104360Abstract: The invention is directed to synthetic receptor(s) which comprises a polyfunctional organic template covalently linked to two or more oligomers which may independently be the same or different and may independently be straight chain, cyclic or branched. The template may be linked to an identifier which uniquely defines the synthetic receptor. The identifier is a stable chemical molecule or a plurality of stable chemical molecules distinguishable and detectable to picomolar levels or may be an oligonucleotide. In a preferred embodiment, the template is covalently linked to a solid support which is linked to an identifier. In addition, the invention includes methods of preparing synthetic receptors and synthetic receptor libraries. The synthetic library may be linked with identifiers such that the library comprises a plurality of different synthetic receptor members.Type: ApplicationFiled: October 24, 1996Publication date: June 5, 2003Inventors: W. CLARK STILL, GE LI, HELMA WENNEMERS
-
Patent number: 6566495Abstract: A synthetic strategy for the creation of large scale chemical diversity. Solid-phase chemistry, photolabile protecting groups, and photolithography are used to achieve light-directed spatially-addressable parallel chemical synthesis. Binary masking techniques are utilized in one embodiment. A reactor system, photoremovable protective groups, and improved data collection and handling techniques are also disclosed. A technique for screening linker molecules is also provided.Type: GrantFiled: December 17, 1999Date of Patent: May 20, 2003Assignee: Affymetrix, Inc.Inventors: Stephen P. A. Fodor, Lubert Stryer, J. Leighton Read, Michael C. Pirrung
-
Patent number: 6566494Abstract: A support material for solid phase synthesis is provided having an amine-containing organic group attached to it through a linker.Type: GrantFiled: May 11, 1999Date of Patent: May 20, 2003Assignee: Regents of the University of MinnesotaInventors: Knud J. Jensen, George Barany, Micheal F. Songster, Fernando Albericio, Jordi Alsina, Josef Vágner
-
Patent number: 6566520Abstract: A method for the preparation and purification of compounds using a novel support, a tetrabenzo [a, c, g, i]-fluorene group (Tbf) comprising reacting a building block (A) containing a Tbf group (Tbf-A), with a second building block (B), to afford an intermediate compound (Tbg-A-B) followed by purifying the intermediate compound by adsorption on a carbon support, removing the intermediate compound from the support with a solvent and repeating the previous reactions using the required number of building blocks to synthesize the compounds followed by removal of the Tbf group to afford the desired compounds.Type: GrantFiled: April 14, 1999Date of Patent: May 20, 2003Assignee: Warner-Lambert CompanyInventors: Sheila Helen DeWitt, Robert Ramage, Alasdair Arthur MacDonald